SOLV
SOLV
US83444M1018
Solventum Corporation
Loading chart...

Company Profile

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Latest News

Related stocks

BAX
BAX • United States
Baxter International Inc.
24.35 USD
12.59B USD 1Y +5.1%
COO
COO • United States
The Cooper Companies, Inc.
54.37 USD
10.34B USD 1Y -22.7%
AVTR
AVTR • United States
Avantor, Inc.
15.67 USD
10.6B USD 1Y +11.9%
RMD
RMD • United States
ResMed Inc.
230.05 USD
32.35B USD 1Y -19.7%
RMD.AX
RMD.AX • United States
RESMED CDI 10:1 [RMD]
32.58 AUD
32.02B USD 1Y -23.3%
RGEN
RGEN • United States
Repligen Corporation
173.88 USD
11.04B USD 1Y +8.6%
MMED
MMED • United States
MiniMed Group, Inc.
19.71 USD
5.55B USD
MDLN
MDLN • United States
Medline Inc.
36.26 USD
48.79B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
31.6% p.a.
Max Drawdown (3Y)
-40.0%
Sharpe Ratio (3Y)
0.02
Beta Factor
0.70
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
ende